A critical advance in cancer investigation is occurring with the use of mini-antibodies to re-engage damaged p53. This vital malignant suppressor protein is frequently disabled in many kinds of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research